Background:

Pre-eclampsia is a generalized vasoconstriction state associated with vascular epithelial dysfunction rather than the vasodilation characteristic of pregnancy, characterized by proteinuric hypertension from the 20th week of pregnancy, sometimes associated with edema; it also causes health risks to the mother and fetus. Traditional clinical treatment uses oral antihypertensive drugs, among these labetalol and extended-release nifedipine are included.

Objective:

To analyze the efficacy of labetalol and nifedipine as an antihypertensive treatment in pre-eclampsia.

Methodology:

Reference sources found in Google Scholar, Science Direct, SciELO, Pubmed, Medes and Elsevier were used. Out of 211 sources, 31 were selected according to inclusion and exclusion criteria.

Conclusions:

It has been determined by majority consensus that oral nifedipine is more effective than labetalol in pre-eclampsia treatment.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )